Excess hepcidin is considered to be a contributing factor to anemia in CKD patients, as it impairs iron absorption from the diet and iron mobilization from body stores, which is suppressed by activation of the HIF pathway (Babitt and Lin, 2010; Batchelor et al., 2020). Here, HAMP is linked to chronic kidney disease.